DEPRESSION, POSTPARTUM
Clinical trials for DEPRESSION, POSTPARTUM explained in plain language.
Never miss a new study
Get alerted when new DEPRESSION, POSTPARTUM trials appear
Sign up with your email to follow new studies for DEPRESSION, POSTPARTUM, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New pill shows promise for moms with severe Post-Baby depression
Disease control CompletedThis study tested a new oral medication called NORA520 as a potential treatment for severe postpartum depression. It involved 93 women who were randomly assigned to receive either the drug or a placebo for 3 days. Researchers measured how well it reduced depression symptoms, its …
Matched conditions: DEPRESSION, POSTPARTUM
Phase: PHASE2 • Sponsor: DuKang Pharmaceuticals, Inc. • Aim: Disease control
Last updated Apr 01, 2026 14:42 UTC
-
Phone app aims to ease new Mothers' hidden struggles
Disease control CompletedThis study tested a digital support program designed to help new mothers. The program used a phone app with mindfulness exercises, music, and video counseling to try to prevent and manage depression and ongoing pain after giving birth. It involved 1,720 women to see if this acces…
Matched conditions: DEPRESSION, POSTPARTUM
Phase: NA • Sponsor: KK Women's and Children's Hospital • Aim: Disease control
Last updated Mar 30, 2026 14:32 UTC
-
Ketamine shows promise for new Moms' pain and mood after surgery
Disease control CompletedThis small, early study aimed to find a safe and tolerable dose of ketamine for women experiencing pain and depression after cesarean delivery. Researchers tested different infusion doses on 12 postpartum women to see which caused the fewest unacceptable side effects like dizzine…
Matched conditions: DEPRESSION, POSTPARTUM
Phase: PHASE1 • Sponsor: Grace Lim, MD, MS • Aim: Disease control
Last updated Mar 27, 2026 12:38 UTC
-
New pill tested to fight severe postpartum depression
Disease control CompletedThis completed Phase 3 trial tested whether an oral medication called LPCN 1154A could safely reduce severe depression symptoms in women with postpartum depression. The study involved 90 women who were within one year of giving birth and had severe depression. Participants were r…
Matched conditions: DEPRESSION, POSTPARTUM
Phase: PHASE3 • Sponsor: Lipocine Inc. • Aim: Disease control
Last updated Mar 27, 2026 12:37 UTC
-
Phone support boosts online course in fight against postpartum depression
Prevention CompletedThis study tested whether adding weekly phone calls to an online parenting course could better prevent depression in new mothers. It involved 510 pregnant women in Quebec who showed early signs of low mood. Researchers compared the full program (course plus calls) to the online c…
Matched conditions: DEPRESSION, POSTPARTUM
Phase: NA • Sponsor: St. Justine's Hospital • Aim: Prevention
Last updated Mar 16, 2026 15:26 UTC